Complications of White-coat Hypertension Compared to a Normotensive and Hypertensive Population.

Autor:	Taher ZA; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, COM-WR, Jeddah, Saudi Arabia.; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia., Khayyat WW; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, COM-WR, Jeddah, Saudi Arabia.; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia., Balubaid MM; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, COM-WR, Jeddah, Saudi Arabia.; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia., Tashkandi MY; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, COM-WR, Jeddah, Saudi Arabia.; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia., Alamoudi SM; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, COM-WR, Jeddah, Saudi Arabia.; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia., Kinsara AJ; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, COM-WR, Jeddah, Saudi Arabia.; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.; Department of Cardiology, Ministry of National Guard-Health Affairs, Jeddah, Saudi Arabia.
Jazyk:	angličtina
Zdroj:	Heart views : the official journal of the Gulf Heart Association [Heart Views] 2021 Jan-Mar; Vol. 22 (1), pp. 8-12. Date of Electronic Publication: 2021 Apr 22.
DOI:	10.4103/HEARTVIEWS.HEARTVIEWS_64_20
Abstrakt:	Background: Accumulating evidence demonstrates that white-coat hypertension (WCH) are associated with several risks and complications. In this study, we aimed to investigate the adverse effects of WCH compared with hypertensive and normotensive patients. Methods: A retrospective cohort study was conducted over five years. Blood pressure (BP) data was collected from both clinic visits and 24-h ambulatory blood pressure monitoring (ABPM) reports. Epidemiological data and complications, cardiac and noncardiac, were also recorded. Results: In total, 286 participants who were followed up for at least three years were included. The sample was divided into 99 normotensive patients (as a control group), 94 patients with clinically diagnosed hypertension (HTN), and 93 patients with WCH. Ischemic heart disease (IHD) was the most noted complication in the WCH group with a relative risk of 9.58 (1.23-74.16) ( P = 0.008). Acute coronary syndrome (ACS) was significantly correlated with a relative risk of 2.06 (0.52-13.38). No significant correlation was noted with noncardiac complications. Both HTN and WCH groups showed a significant association with blood pressure variability (BPV). WCH was associated with an increased BPV in ambulatory daytime systolic measurements ( P = 0.031) and a unique increase in diastolic measurement variability in office BP measurements ( P = 0.020). Conclusion: WCH should be managed as HTN. WCH is associated with cardiac complications, particularly IHD, specifically in patients 55 years and older. WCH was significantly associated with a higher BPV in both ABPM and office-based measurements. Competing Interests: There are no conflicts of interest. (Copyright: © 2021 Heart Views.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu PDF